Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00882544 · ClinicalTrials.gov registry record
Prospective Pediatric Pyeloplasty Robotic Surgical Database
A clinical trial of Hydronephrosis, sponsored by Connecticut Children's Medical Center.
- Completed
- Registry status
- 78
- Enrollment target
- 1
- Study location
NCT00882544 is a study of Hydronephrosis that has completed, run by Connecticut Children's Medical Center. The registered enrollment target is 78 participants, below the 818-participant average among 3 other Hydronephrosis trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00882544, a study of Hydronephrosis, has completed, sponsored by Connecticut Children's Medical Center.
- COMPLETED
- Registry status
- 78 participants
- Enrollment target
- 1
- Study location
Study Summary
Performance and outcomes measure are, at this time, relatively unknown for robotic pyeloplasty procedures. The purpose of this study is to provide a clearer understanding of the urology department's robotic pyeloplasty quality and outcomes measures. This will be accomplished by prospectively collecting data for these procedures would ensure that measures are consistently collected in accordance with a defined protocol, allowing for more valuable quality and clinical research analysis. Hypothesis will be defined before data analysis is performed. Amendments specifying future hypothesis will be submitted the IRB at the appropriate time.
Conditions Studied
Study Locations (1)
Connecticut
- Connecticut Children's Medical Center - Hartford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 78 participants |
| Start Date | 2009-03 |
| Est. Completion | 2016-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00882544
The ClinicalTrials.gov registry entry for NCT00882544 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 78 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 818-participant average among 3 other Hydronephrosis trials with a reported enrollment target (90% lower). The listed sponsor is Connecticut Children's Medical Center, which has 55 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Hydronephrosis appearing as the primary indexed condition, and to 0 interventions.
NCT00882544 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.
Frequently Asked Questions
What is clinical trial NCT00882544 about?
NCT00882544 is a clinical study titled "Prospective Pediatric Pyeloplasty Robotic Surgical Database". Performance and outcomes measure are, at this time, relatively unknown for robotic pyeloplasty procedures. The purpose of this study is to provide a clearer understanding of the urology department's robotic pyeloplasty quality and outcomes measures. This will be accomplished by prospectively collect...
What is the current status of trial NCT00882544?
This trial is currently completed. The enrollment target is 78 participants. The study started on 2009-03. Estimated completion is 2016-10.
What conditions does trial NCT00882544 study?
This clinical trial studies the following conditions: Hydronephrosis.
Who is sponsoring clinical trial NCT00882544?
This trial is sponsored by Connecticut Children's Medical Center, which has 55 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00882544 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hydronephrosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Durvalumab and Tremelimumab in Treating Patients With Muscle-Invasive, High-Risk Urothelial Cancer That Cannot Be Treated With Cisplatin-Based Therapy Before Surgery
ACTIVE NOT RECRUITING · Early Phase 1
-
Sensitivity and Specificity of NGAL in an Emergency Room Population
COMPLETED
-
Hydronephrosis on Ultrasound With CT Finding in Patients With Renal Colic
COMPLETED
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.